TOP NEWS: AstraZeneca's Fasenra Trial Fails To Meet Primary Endpoint
LONDON (Alliance News) - AstraZeneca PLC said Friday that a drug trial for treating chronic obstructive pulmonary disease did not meet its primary end-point.The pharmaceutical company said Read More